Representative Investments
News Provided By our Investments
- Experienced Life Sciences Executive to Join Intrexon as Chief Operating Officer
- Prior CEOs of Monsanto and Pfizer join Intrexon Board of Directors
- Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
- Intrexon Acquires Immunologix, Inc.

